Z2区TEVAR中左锁骨下动脉血运重建与较低卒中风险相关
这项回顾性队列研究纳入2007至2014年96例接受Z2区TEVAR的主动脉疾病患者,比较左锁骨下动脉(LSA)覆盖是否重建及不同重建方式。
要点
- Z2区TEVAR覆盖LSA时,未行血运重建与30天卒中风险显著升高相关。
- LSA重建与TEVAR同期或分期进行,卒中率无显著差异。
核心结论
- Z2区TEVAR中覆盖LSA而未行血运重建增加卒中风险,并可能增加脊髓损伤风险。
研究设计与样本
- 回顾性病历审查,纳入2007至2014年96例接受Z2区TEVAR的任何主动脉疾病患者。
- LSA策略为覆盖伴血运重建54例或不伴血运重建42例。
- 血运重建方式包括激光开窗支架33例、手术转位10例、旁路11例。
主要发现
- 全队列30天卒中发生率7.3%,30天脊髓损伤2.1%,手术相关再干预5.2%。
- 中位随访24个月,主动脉相关再干预15.6%,主动脉相关死亡12.5%,全因死亡29.2%。
临床怎么用
- Z2区TEVAR需覆盖LSA时,应考虑行血运重建以降低围术期卒中风险。
- 血运重建可与TEVAR同期或分期进行,本研究未显示两者卒中率差异。
局限性
- 回顾性单中心设计,样本量96例,部分终点事件数少。
- LSA未重建组卒中风险估计的置信区间宽(1.3-220.4),需谨慎解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The best management strategy for the left subclavian artery (LSA) in pathologic processes of the aorta requiring zone 2 thoracic endovascular aortic repair (TEVAR) remains controversial. We compared LSA coverage with or without revascularization as well as the different means of LSA revascularization. METHODS: A retrospective chart review was conducted of patients with any aortic diseases who underwent zone 2 TEVAR deployment from 2007 to 2014. Primary end points included 30-day stroke and 30-day spinal cord injury (SCI). Secondary end points were 30-day procedure-related reintervention, freedom from aorta-related reintervention, aorta-related mortality, and all-cause mortality. RESULTS: We identified 96 patients with zone 2 TEVAR who met our inclusion criteria. The mean age of the patients was 62 years, with 61.5% male. Diseases included acute aortic dissections (n = 25), chronic aortic dissection with aneurysmal degeneration (n = 22), primary aortic aneurysms (n = 21), penetrating aortic ulcers/intramural hematomas (n = 17), and traumatic aortic injuries (n = 11). Strategies for the LSA included coverage with revascularization (n = 54) or without revascularization (n = 42). Methods of LSA revascularization included laser fenestration with stenting (n = 33) and surgical revascularization: transposition (n = 10) or bypass (n = 11). Of the 54 patients with LSA revascularization, 44 (81.5%) underwent LSA intervention at the time of TEVAR and 10 (18.5%) at a mean time of 33 days before TEVAR (range, 4-63 days). For the entire cohort, the overall incidence of 30-day stroke was 7.3%; of 30-day SCI, 2.1%; and of procedure-related reintervention, 5.2%. At a mean follow-up of 24 months (range, 1-79 months), aorta-related reintervention was 15.6%, aorta-related mortality was 12.5%, and all-cause mortality was 29.2%. The 30-day stroke rate was highest for LSA coverage without revascularization (6/42 [14.3%]) compared with any form of LSA revascularization (1/54 [1.9%]; P = .020), with no difference between LSA interventions done synchronously with TEVAR (1/44 [2.3%]) vs metachronously with TEVAR (0/10 [0%]; P = .63). There was no significant difference in 30-day SCI in LSA coverage without revascularization (2/42 [4.8%]) vs with revascularization (0/54 [0%]; P = .11). There was no difference in aorta-related reintervention, aorta-related mortality, or all-cause mortality in coverage without revascularization (5/42 [11.9%], 6/42 [14.3%], and 14/42 [33.3%]) vs with revascularization (10/54 [18.5%; P = .376], 6/54 [11.1%; P = .641], and 14/54 [25.9%; P = .43], respectively). After univariate and multivariable analysis, we identified LSA coverage without revascularization as associated with a higher rate of 30-day stroke (hazard ratio, 17.2; 95% confidence interval, 1.3-220.4; P = .029). CONCLUSIONS: Our study suggests that coverage of the LSA without revascularization increases the risk of stroke and possibly SCI.
引用
- Bradshaw RJ, Ahanchi SS, Powell O, et al. Left subclavian artery revascularization in zone 2 thoracic endovascular aortic repair is associated with lower stroke risk across all aortic diseases. J Vasc Surg. 2017. PMID: 28216353. doi:10.1016/j.jvs.2016.10.111
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。